Seminars in Radiation Oncology
Volume 16, Issue 2 , Pages 67-76 , April 2006

Stereotactic Body Radiation Therapy for Extracranial Oligometastases: Does the Sword Have a Double Edge?

  • Madeleine Carey Sampson, MD
  • ,
  • Alan Katz, MD, MPH
  • ,
  • Louis S. Constine, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Louis S. Constine, MD, Department of Radiation Oncology, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue Box 647, Rochester, NY 14642.

References 

  1. Jemal A , Murray T , Ward E , Samuels A , Tiwari RC , Ghafoor A , et al.   Cancer Statistics, 2005 . CA Cancer J Clin . 2005;55:10–30
  2. Fong Y , Fortner J , Sun RL , et al.   Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer (Analysis of 1001 consecutive cases) . Ann Surg . 1999;230:309–318
  3. Greenberg PA , Hortobagyi GN , Smith TL , et al.   Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer . J Clin Oncol . 1996;14:2197–2205
  4. Falkson G , Gelman RS , Leone L , et al.   Survival of premenopausal women with metastatic breast cancer. Long-term follow-up of Eastern Cooperative Group and Cancer and Leukemia Group B studies . Cancer . 1990;66:1621–1629
  5. Fuss M , Thomas CR . Stereotactic body radiation therapy (An ablative treatment option for primary and secondary liver tumors) . Ann Surg Oncol . 2004;11:130–138
  6. Graham MV , Purdy JA , Emami B , et al.   Clinical dose–volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC) . Int J Radiat Oncol Biol Phys . 1999;45(2):323–329
  7. Hernando ML , Marks LB , Bentel GC , et al.   Radiation-induced pulmonary toxicity (A dose-volume histogram analysis in 201 patients with lung cancer) . Int J Radiat Oncol Biol Phys . 2001;51:650–659
  8. Oetzel D , Schraube P , Hensley F , et al.   Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis . Int J Radiat Oncol Biol Phys . 1995;33:455–460
  9. Kwa SL , Lebesque JV , Theuws JC , et al.   Radiation pneumonitis as a function of mean lung dose (An analysis of pooled data of 540 patients) . Int J Radiat Oncol Biol Phys . 1998;42:1–9
  10. Choi N , Kanarek DJ , Kazemi H . Physiologic changes in pulmonary function after thoracic radiotherapy for patients with lung cancer and role of regional pulmonary perfusion studies in predicting post-radiotherapy pulmonary function before radiotherapy . Cancer Treat Symp . 1985;2:119–130
  11. Morgan GW , Freeman AP , McLean RG , et al.   Late cardiac, thyroid, and pulmonary sequelae of mantle radiotherapy for Hodgkin’s disease . Int J Radiat Oncol Biol Phys . 1985;11:1925–1931
  12. Fu X-L , Huang H , Bentel G , et al.   Predicting the risk of symptomatic radiation-induced lung injury using both the physical and biologic parameters V30 and transforming growth factor β . Int J Radiat Oncol Biol Phys . 2001;50:899–908
  13. Chen Y , Williams J , Hernady E , et al.   Radiation pneumonitis and early circulatory cytokine markers . Semin Radiat Oncol . 2002;12(suppl 1):26–33
  14. Seppenwoolde Y , Engelsman M , De Jaeger K , et al.   Optimizing radiation treatment plans for lung cancer using lung perfusion information . Radiother Oncol . 2002;63:165–177
  15. Common Terminology Criteria for Adverse Events version 3.0 (CTCAE v3.0), Cancer Therapy Evaluation Program . 2005; Available at: http://ctep.cancer.gov/reporting/ctc.html. Accessed August 23
  16. Jirtle RL , Anscher MS , Alati T , et al.   Radiation sensitivity of the liver . Adv Radiat Biol . 1990;14:269–311
  17. Dawson LA , McGinn CJ , Normolle D , et al.   Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies . J Clin Oncol . 2000;18:2210–2218
  18. Schefter TE , Kavanagh BD , Timmerman RD , et al.   A Phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases . Int J Radiat Oncol Biol Phys . 2005;62:1371–1378
  19. Blomgren H , Lax I , NäslundI  , et al.   Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator . Acta Oncol . 1995;34:861–870
  20. Ryu S , Yin FF , Rock J , et al.   Image-guided and intensity-modulated radiosurgery for patients with spinal metastasis . Cancer . 2003;97:2013–2018
  21. Blomgren H , Lax I , Göranson H , et al.   Radiosurgery for tumors in the body (Clinical experience using a new method) . J Radiosurg . 1998;1:63–74
  22. Uematsu M , Shioda A , Tahara K , et al.   Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients . Cancer . 1998;82:1062–1070
  23. Wulf J , Hadinger U , Oppitz U , et al.   Stereotactic radiotherapy of targets in lung and liver . Strahlenther Onkol . 2001;177:645–655
  24. Nakagawa K , Aoki Y , Tago M , et al.   Megavoltage C.T-assisted stereotactic radiosurgery for thoracic tumors (Original research in the treatment of thoracic neoplasms) . Int J Radiat Oncol Biol Phys . 2000;48:449–457
  25. Fukumoto S , Hiroki S , Shinichi S , et al.   Small-volume image-guided radiotherapy using hypofractionated, coplanar, and noncoplanar multiple fields for patients with inoperable stage 1 nonsmall cell lung carcinomas . Cancer . 2002;95:1547–1553
  26. Nagata Y , Negoro Y , Aoki T , et al.   Clinical outcomes of 3D conformal hypofractionated single high dose radiotherapy for one or two lung tumors using a stereotactic body frame . Int J Radiat Oncol Biol Phys . 2002;52:1041–1046
  27. Hof H , Herfarth K , Münter M , et al.   Stereotactic single-dose radiotherapy of stage I non-small cell lung cancer . Int J Radiat Oncol Biol Phys . 2003;56:335–341
  28. Timmerman R , Papiez L , McGarry R , et al.   Extracranial stereotactic radioablation (Results of a phase I study in medically inoperable stage I non-small cell lung cancer) . Chest . 2003;124:1946–1955
  29. Hara R , Itami J , Kondo T , et al.   Stereotactic single high dose irradiation of lung tumors under respiratory gating . Radiother Oncol . 2002;63:159–163
  30. Lee S , Choi E , Park H , et al.   Stereotactic body frame based fractionated radiosurgery on consecutive days for primary or metastatic tumors in the lung . Lung Cancer . 2003;40:309–315
  31. Onimaru R , Shirato H , Shimizu S , et al.   Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers . Int J Radiat Oncol Biol Phys . 2003;56:126–135
  32. Uematsu M , Wong J , Shioda A , et al.   CT-guided stereotactic radiation therapy for stage I non-small cell lung cancers . Lung Cancer . 2003;S243: Poster 809
  33. Uematsu M , Shioda M , Suda A , et al.   Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer (A 5-year experience) . Int J Radiat Oncol Biol Phys . 2001;51:666–670
  34. Whyte R , Crownover R , Murphy M , et al.   Stereotactic radiosurgery for lung tumors (Preliminary report of a phase I trial) . Ann Thorac Surg . 2003;75:1097–1101
  35. Onishi H , Araki T , Shirato H , et al.   Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma (Clinical outcomes in 245 subjects in a Japanese multiinstitutional study) . Cancer . 2004;101:1623–1630
  36. Wulf J , Haedinger U , Oppitz U , et al.   Stereotactic radiotherapy for primary lung cancer and pulmonary metastases (A noninvasive treatment approach in medically inoperable patients) . Int J Radiat Oncol Biol Phys . 2004;60:186–196
  37. Sato M , Uematsu M , Yamamoto F , et al.   Feasability of frameless stereotactic high-dose radiation therapy for primary or metastatic liver cancer . J Radiosurg . 1998;1:233–238
  38. Herfarth KK , Debus J , Lohr F , et al.   Stereotactic single-dose radiation therapy of liver tumors (Results of a phase I/II trial) . J Clin Oncol . 2001;19:164–170
  39. Wada H , Takai Y , Nemoto K , et al.   Univariate analysis of factors correlated with tumor control probability of three-dimensional conformal hypofractionated high-dose radiotherapy for small pulmonary or hepatic tumors . Int J Radiat Oncol Biol Phys . 2004;58:1114–1120
  40. Sloan JA , Goldberg RM , Sargent DJ , et al.   Women experience greater toxicity with fluorouracil-based chemotherapy for colorectal cancer . J Clin Oncol . 2002;20:1491–1498
  41. Andre T , Boni C , Mounedji-Boudiaf L , et al.   Oxaliplatin, flourouracil, and luecovorin as adjuvant treatment for colon cancer . N Engl J Med . 2004;350:2343–2351
  42. de Gramont A , Figer A , Seymour M , et al.   Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer . J Clin Oncol . 2000;18:2938–2947
  43. Abigerges D , Chabot GG , Armand JP , et al.   Phase I and pharmacologic studies of the camptothecin analog irinotecan administered every 3 weeks in cancer patients . J Clin Oncol . 1995;13:210–221
  44. Feliu J , Escudero P , Llosa F , et al.   Capecitabine as first-line treatment for patients older than 70 years with metastatic colorectal cancer (An oncopaz cooperative group study) . J Clin Oncol . 2005;23:3104–3111
  45. Blum JL , Dieras V , Lo Russo PM , et al.   Multicenter, phase II study of capecitabine in taxane-pretreated metastatic breast carcinoma patients . Cancer . 2001;92:1759–1768
  46. Tomiak E , Piccart MJ , Kerger J , et al.   Phase I study of docetaxel administered as a 1-hour intravenous infusion on a weekly basis . J Clin Oncol . 1994;1:1458–1467
  47. Cobleigh MA , Vogel CL , Tripathy D , et al.   Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease . J Clin Oncol . 1999;17:2639–2648
  48. Gillams AR . Liver ablation therapy . Br J Radiol . 2004;77:713–723
  49. Chao KS , Perez C , Brady L . Radiation Oncology (Management Decisions) . New York, NY: Lippincott Williams and Wilkins; 2002; p 1

PII: S1053-4296(05)00097-4

doi: 10.1016/j.semradonc.2005.12.002

Seminars in Radiation Oncology
Volume 16, Issue 2 , Pages 67-76 , April 2006